These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25432720)

  • 41. Metabolic alterations in Parkinson's disease astrocytes.
    Sonninen TM; Hämäläinen RH; Koskuvi M; Oksanen M; Shakirzyanova A; Wojciechowski S; Puttonen K; Naumenko N; Goldsteins G; Laham-Karam N; Lehtonen M; Tavi P; Koistinaho J; Lehtonen Š
    Sci Rep; 2020 Sep; 10(1):14474. PubMed ID: 32879386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglia and astrocyte dysfunction in parkinson's disease.
    Kam TI; Hinkle JT; Dawson TM; Dawson VL
    Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration.
    Zhang S; Xie J; Xia Y; Yu S; Gu Z; Feng R; Luo G; Wang D; Wang K; Jiang M; Cheng X; Huang H; Zhang W; Wen T
    Sci Rep; 2015 Jul; 5():12564. PubMed ID: 26220523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats.
    Daher JP; Volpicelli-Daley LA; Blackburn JP; Moehle MS; West AB
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9289-94. PubMed ID: 24927544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.
    Wilson GR; Sim JC; McLean C; Giannandrea M; Galea CA; Riseley JR; Stephenson SE; Fitzpatrick E; Haas SA; Pope K; Hogan KJ; Gregg RG; Bromhead CJ; Wargowski DS; Lawrence CH; James PA; Churchyard A; Gao Y; Phelan DG; Gillies G; Salce N; Stanford L; Marsh AP; Mignogna ML; Hayflick SJ; Leventer RJ; Delatycki MB; Mellick GD; Kalscheuer VM; D'Adamo P; Bahlo M; Amor DJ; Lockhart PJ
    Am J Hum Genet; 2014 Dec; 95(6):729-35. PubMed ID: 25434005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropathology of PARK14 is identical to idiopathic Parkinson's disease.
    Miki Y; Yoshizawa T; Morohashi S; Seino Y; Kijima H; Shoji M; Mori A; Yamashita C; Hatano T; Hattori N; Wakabayashi K
    Mov Disord; 2017 May; 32(5):799-800. PubMed ID: 28211602
    [No Abstract]   [Full Text] [Related]  

  • 51. LRRK2 protein is a component of Lewy bodies.
    Zhu X; Siedlak SL; Smith MA; Perry G; Chen SG
    Ann Neurol; 2006 Nov; 60(5):617-618. PubMed ID: 16847950
    [No Abstract]   [Full Text] [Related]  

  • 52. The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriers.
    Toffoli M; Smith L; Schapira AHV
    J Neurochem; 2020 Jul; 154(1):11-24. PubMed ID: 31965564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What lysosomes actually tell us about Parkinson's disease?
    Bourdenx M; Dehay B
    Ageing Res Rev; 2016 Dec; 32():140-149. PubMed ID: 26947123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic dysfunction in genetic forms of synucleinopathies.
    Chelban V; Vichayanrat E; Schottlaende L; Iodice V; Houlden H
    Mov Disord; 2018 Mar; 33(3):359-371. PubMed ID: 29508456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two hundred steps.
    Drew L
    Nature; 2016 Oct; 538(7626):S2-S3. PubMed ID: 27783577
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease.
    Dolgacheva LP; Zinchenko VP; Goncharov NV
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson's Disease.
    Lamonaca G; Volta M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.
    Burbulla LF; Krainc D
    Neurobiol Dis; 2019 Dec; 132():104545. PubMed ID: 31351996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.
    Wurtman RJ
    Metabolism; 2013 Jan; 62 Suppl 1():S27-9. PubMed ID: 22999712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in the genetics of dementia with lewy bodies.
    Bonifati V
    Curr Neurol Neurosci Rep; 2008 May; 8(3):187-9. PubMed ID: 18541113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.